KRT19 is a promising prognostic biomarker and associates with immune infiltrates in serous ovarian cystadenocarcinoma

Z Sun, R Zhou, J Dai, J Chen, Y Liu… - … Journal of General …, 2023 - Taylor & Francis
Background Ovarian cancer (OV) is the highest prevalent gynecologic tumor with
complicated pathogenesis; high-grade serous ovarian cystadenocarcinoma (HGSOC) is the …
被引用次数：2 相关文章

KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma

Z Sun, R Zhou, J Dai, J Chen, Y Liu… - … journal of general …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Ovarian cancer (OV) is the highest prevalent gynecologic tumor with
complicated pathogenesis; high-grade serous ovarian cystadenocarcinoma (HGSOC) is the …
[HTML] nih.gov

[HTML][HTML] KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma

Z Sun, R Zhou, J Dai, J Chen, Y Liu… - … Journal of General …, 2023 - ncbi.nlm.nih.gov
Background Ovarian cancer (OV) is the highest prevalent gynecologic tumor with
complicated pathogenesis; high-grade serous ovarian cystadenocarcinoma (HGSOC) is the …

KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma.

Z Sun, R Zhou, J Dai, J Chen, Y Liu… - … Journal of General …, 2023 - europepmc.org
Background Ovarian cancer (OV) is the highest prevalent gynecologic tumor with
complicated pathogenesis; high-grade serous ovarian cystadenocarcinoma (HGSOC) is the …

KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma

Z Sun, R Zhou, J Dai, J Chen, Y Liu… - … Journal of General …, 2023 - dovepress.com
Background: Ovarian cancer (OV) is the highest prevalent gynecologic tumor with
complicated pathogenesis; high-grade serous ovarian cystadenocarcinoma (HGSOC) is the …